Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation
| Autor: | Wael A. Jaber, Oussama M. Wazni, Mohamed B. Elshazly, Bryan Wilner, Mohamed Kanj, Kevin Trulock, Divyang Patel, Daniel J. Cantillon, Eoin Donnellan, Bryan Baranowski, Niraj Varma, Walid Saliba, Ayman A. Hussein |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment 030204 cardiovascular system & hematology Cardioversion 03 medical and health sciences 0302 clinical medicine Weight loss Recurrence Risk Factors Physiology (medical) Internal medicine Atrial Fibrillation medicine Humans 030212 general & internal medicine Ejection fraction business.industry Sleep apnea Atrial fibrillation medicine.disease Obesity Morbid Blood pressure Treatment Outcome Heart failure Cardiology Catheter Ablation medicine.symptom Cardiology and Cardiovascular Medicine business Body mass index |
| Zdroj: | Journal of cardiovascular electrophysiologyREFERENCES. 31(8) |
| ISSN: | 1540-8167 |
| Popis: | BACKGROUND Morbid obesity is associated with prohibitively high arrhythmia recurrence rates following atrial fibrillation (AF) ablation. DESIGN This was a single-center study comprising 239 patients with morbid obesity and symptomatic paroxysmal or persistent AF undergoing AF ablation compared to 239 patients with a body mass index less than 30 kg/m2 matched based on age, sex, ejection fraction, AF type, presence and type of heart failure, and left atrial volume index. METHODS Our primary outcome of interest was arrhythmia recurrence. RESULTS During a mean follow-up of 29 months, arrhythmia recurrence was observed in 65% of the morbidly obese cohort compared to 27% of the control group (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text